Literature DB >> 26611948

Neuroimaging-evident lesional pathology associated with REM sleep behavior disorder.

Stuart J McCarter1, Maja Tippmann-Peikert1, David J Sandness1, Eoin P Flanagan2, Kejal Kantarci3, Bradley F Boeve1, Michael H Silber1, Erik K St Louis4.   

Abstract

BACKGROUND/RATIONALE: Rapid eye movement (REM) sleep behavior disorder (RBD) is a potentially injurious parasomnia characterized by dream enactment behavior and polysomnographic REM sleep without atonia (RSWA). Recently, RBD not only has been shown to be strongly associated with synucleinopathy neurodegeneration but has also been rarely reported to be associated with structural lesions involving the brainstem or limbic system. The aim of this study was to describe the clinical, neuroimaging, and outcome characteristics in a case series of patients with lesional RBD.
METHODS: This is a retrospective case series from a tertiary care referral center.
RESULTS: A total of 10 patients with lesional RBD were identified. Seven (70%) were men, with an average age of sleep symptom onset of 53.7 ± 17.0 years. Structural pathology evident on neuroimaging included four extraaxial (three meningiomas and one basilar fusiform aneurysm with brainstem compression) and six intraaxial (encephalomalacia, multiple sclerosis, vasculitis, autoimmune limbic encephalitis, and leukodystrophy) lesions. No patient developed parkinsonian features or cognitive impairment suggestive of synucleinopathy over an average of 45.4 ± 35.2 months of follow-up.
CONCLUSIONS: RBD is rarely associated with non-synuclein structural lesions affecting the pons, medulla, or limbic system. The spectrum of lesional RBD comprises tumors, aneurysms, leukodystrophy, and autoimmune/inflammatory/demyelinating brain lesions.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Brain lesion; Neuroimaging; Outcome; Parasomnia; REM sleep behavior disorder

Mesh:

Year:  2015        PMID: 26611948     DOI: 10.1016/j.sleep.2015.07.018

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  14 in total

Review 1.  Idiopathic REM sleep behaviour disorder and neurodegeneration - an update.

Authors:  Birgit Högl; Ambra Stefani; Aleksandar Videnovic
Journal:  Nat Rev Neurol       Date:  2017-11-24       Impact factor: 42.937

2.  Neuromelanin-sensitive imaging in patients with idiopathic rapid eye movement sleep behaviour disorder.

Authors:  Bradley F Boeve; Erik K St Louis; Kejal Kantarci
Journal:  Brain       Date:  2016-04       Impact factor: 13.501

Review 3.  Cognitive Decline in Older People with Multiple Sclerosis-A Narrative Review of the Literature.

Authors:  Hsueh-Sheng Chiang; Alka Khera; Barbara E Stopschinski; Olaf Stuve; John Hart; Brendan Kelley; Trung Nguyen
Journal:  Geriatrics (Basel)       Date:  2022-06-05

Review 4.  Treatment of REM Sleep Behavior Disorder.

Authors:  Youngsin Jung; Erik K St Louis
Journal:  Curr Treat Options Neurol       Date:  2016-11       Impact factor: 3.598

5.  Dream enactment behavior: review for the clinician.

Authors:  Marc Baltzan; Chun Yao; Dorrie Rizzo; Ron Postuma
Journal:  J Clin Sleep Med       Date:  2020-11-15       Impact factor: 4.062

Review 6.  The anatomical, cellular and synaptic basis of motor atonia during rapid eye movement sleep.

Authors:  Elda Arrigoni; Michael C Chen; Patrick M Fuller
Journal:  J Physiol       Date:  2016-07-03       Impact factor: 5.182

Review 7.  REM Sleep Behavior Disorder: Diagnosis, Clinical Implications, and Future Directions.

Authors:  Erik K St Louis; Bradley F Boeve
Journal:  Mayo Clin Proc       Date:  2017-11-01       Impact factor: 7.616

Review 8.  Sleep Disturbances in Patients with Autoimmune Encephalitis.

Authors:  Margaret S Blattner; Gregory S Day
Journal:  Curr Neurol Neurosci Rep       Date:  2020-06-10       Impact factor: 5.081

Review 9.  Current Concepts and Controversies in the Management of REM Sleep Behavior Disorder.

Authors:  E Matar; S J McCarter; E K St Louis; S J G Lewis
Journal:  Neurotherapeutics       Date:  2021-01-06       Impact factor: 7.620

10.  Objective sleep profile in LGI1/CASPR2 autoimmunity.

Authors:  Michelle F Devine; John C Feemster; Elizabeth A Lieske; Stuart J McCarter; David J Sandness; Tyler Steele; Paul C Timm; Jay Mandrekar; Bradley F Boeve; Michael H Silber; Divyanshu Dubey; Andrew McKeon; Erik K St Louis
Journal:  Sleep       Date:  2022-02-14       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.